학술논문
Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study
Document Type
Article
Author
DeJesus, Edwin; Ramgopal, Moti; Crofoot, Gordon; Ruane, Peter; LaMarca, Anthony; Mills, Anthony; Martorell, Claudia T; de Wet, Joseph; Stellbrink, Hans-Jürgen; Molina, Jean-Michel; Post, Frank A; Valero, Ignacio Pérez; Porter, Danielle; Liu, YaPei; Cheng, Andrew; Quirk, Erin; SenGupta, Devi; Cao, Huyen
Source
In The Lancet HIV May 2017 4(5):e205-e213
Subject
Language
ISSN
2352-3018